Role of splice variants in the metastatic progression of prostate cancer

Biochemical Society Transactions

Volumn 40, Issue 4, 2012, Pages 870-874

  Hagen, Rachel M ^a   Ladomery, Michael R ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

Alternative splicing; Central alternative exon; Epidermal growth factor; Metastasis; Prolactin; Prostate cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROLACTIN RECEPTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; CANCER SURVIVAL; CONFERENCE PAPER; EPITHELIAL MESENCHYMAL TRANSITION; GENE SEQUENCE; HUMAN; INTRON; METASTASIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL RATE; SURVIVAL TIME;

ALTERNATIVE SPLICING; ANIMALS; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; RNA SPLICING;

EID: 84864383743     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120026     Document Type: Conference Paper

References (50)

1. Alt, F.W., Bothwell, A.L., Knapp, M., Siden, E., Mather, E., Koshland, M. and Baltimore, D. (1980) Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ ends. Cell 20, 293-301 (Pubitemid 10117745)
2. Early, P., Rogers, J., Davis, M., Calame, K., Bond, M., Wall, R. and Hood, L. (1980) Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways. Cell 20, 313-319 (Pubitemid 10117747)
3. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431, 931-945
4. Pan, Q., Shai, O., Lee, L.J., Frey, B.J. and Blencowe, B.J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genet. 40, 1413-1415
5. Wang, E.T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S.F., Schroth, G.P. and Burge, C.B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476 (Pubitemid 352759009)
6. David, C.J. and Manley, J.L. (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343-2364
7. Wahl, M.C., Will, C.L. and Luhrmann, R. (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136, 701-718
8. Blencowe, B.J. (2006) Alternative splicing: new insights from global analyses. Cell 126, 37-47
9. Nilsen, T.W. and Graveley, B.R. (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463, 457-463
10. Schwerk, C. and Schulze-Osthoff, K. (2005) Regulation of apoptosis by alternative pre-mRNA splicing. Mol. Cell 19, 1-13 (Pubitemid 40884653)
11. Blencowe, B.J. (2000) Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25, 106-110
12. Black, D.L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336
13. Venables, J.P., Klinck, R., Koh, C., Gervais-Bird, J., Bramard, A., Inkel, L., Durand, M., Couture, S., Froehlich, U., Lapointe, E. et al. (2009) Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16, 670-676
14. Skotheim, R.I. and Nees, M. (2007) Alternative splicing in cancer: noise, functional, or systematic? Int. J. Biochem. Cell Biol. 39, 1432-1449
15. Srebrow, A. and Kornblihtt, A.R. (2006) The connection between splicing and cancer. J. Cell Sci. 119, 2635-2641 (Pubitemid 44184000)
16. Kim, E., Goren, A. and Ast, G. (2008) Insights into the connection between cancer and alternative splicing. Trends Genet. 24, 7-10 (Pubitemid 350298628)
17. Lee, C. and Wang, Q. (2005) Bioinformatics analysis of alternative splicing. Brief. Bioinform. 6, 23-33 (Pubitemid 40528577)
18. Kechris, K., Yang, Y.H. and Yeh, R.F. (2008) Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays. BMC Genomics 9, 551
19. Barash, Y., Calarco, J.A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B.J. and Frey, B.J. (2010) Deciphering the splicing code. Nature 465, 53-59
20. Fackenthal, J.D. and Godley, L.A. (2008) Aberrant RNA splicing and its functional consequences in cancer cells. Dis. Models Mech. 1, 37-42
21. Ni, J.Z., Grate, L., Donohue, J.P., Preston, C., Nobida, N., O'Brien, G., Shiue, L., Clark, T.A., Blume, J.E. and Ares, Jr, M. (2007) Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev. 21, 708-718 (Pubitemid 46440292)
22. Chen, M. and Manley, J.L. (2009) Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10, 741-754
23. Shapiro, I.M., Cheng, A.W., Flytzanis, N.C., Balsamo, M., Condeelis, J.S., Oktay, M.H., Burge, C.B. and Gertler, F.B. (2011) An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 7, e1002218
24. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. and Thun, M.J. (2007) Cancer statistics, 2007. Ca-Cancer J. Clin. 57, 43-66 (Pubitemid 46148091)
25. Hugo, H., Ackland, M.L., Blick, T., Lawrence, M.G., Clements, J.A., Williams, E.D. and Thompson, E.W. (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell. Physiol. 213, 374-383 (Pubitemid 47509716)
26. Bozzuto, G., Ruggieri, P. and Molinari, A. (2010) Molecular aspects of tumor cell migration and invasion. Ann. Ist. Super. Sanita 46, 66-80
27. Karayi, M.K. and Markham, A.F. (2004) Molecular biology of prostate cancer. Prostate Cancer Prostatic Dis. 7, 6-20 (Pubitemid 38443526)
28. Kingsley, L.A., Fournier, P.G., Chirgwin, J.M. and Guise, T.A. (2007) Molecular biology of bone metastasis. Mol. Cancer Ther. 6, 2609-2617 (Pubitemid 350058141)
29. Bonfil, R.D., Chinni, S., Fridman, R., Kim, H.R. and Cher, M.L. (2007) Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis. Urol. Oncol. 25, 407-411 (Pubitemid 47362762)
30. Morrissey, C. and Vessella, R.L. (2007) The role of tumor microenvironment in prostate cancer bone metastasis. J. Cell. Biochem. 101, 873-886 (Pubitemid 47040869)
31. Petrovics, G., Liu, A., Shaheduzzaman, S., Furusato, B., Sun, C., Chen, Y., Nau, M., Ravindranath, L., Chen, Y., Dobi, A. et al. (2005) Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24, 3847-3852 (Pubitemid 40826884)
32. Tomlins, S.A., Rhodes, D.R., Perner, S., Dhanasekaran, S.M., Mehra, R., Sun, X.W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R. et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648 (Pubitemid 41528150)
33. Tomlins, S.A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B.E., Cao, Q., Prensner, J.R., Rubin, M.A., Shah, R.B. et al. (2008) Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10, 177-188 (Pubitemid 351240884)
34. Gupta, S., Iljin, K., Sara, H., Mpindi, J.P., Mirtti, T., Vainio, P., Rantala, J., Alanen, K., Nees, M. and Kallioniemi, O. (2010) FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 70, 6735-6745
35. Flajollet, S., Tian, T.V., Flourens, A., Tomavo, N., Villers, A., Bonnelye, E., Aubert, S., Leroy, X. and Duterque-Coquillaud, M. (2011) Abnormal expression of the ERG transcription factor in prostate cancer cells activates osteopontin. Mol. Cancer Res. 9, 914-924
36. Wang, J., Cai, Y., Yu, W., Ren, C., Spencer, D.M. and Ittmann, M. (2008) Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts. Cancer Res. 68, 8516-8524
37. Owczarek, C.M., Portbury, K.J., Hardy, M.P., O'Leary, D.A., Kudoh, J., Shibuya, K., Shimizu, N., Kola, I. and Hertzog, P.J. (2004) Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. Gene 324, 65-77 (Pubitemid 38030326)
38. Jhavar, S., Reid, A., Clark, J., Kote-Jarai, Z., Christmas, T., Thompson, A., Woodhouse, C., Ogden, C., Fisher, C., Corbishley, C. et al. (2008) Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. J. Mol. Diagn. 10, 50-57 (Pubitemid 351184835)
39. Jacobson, E.M., Hugo, E.R., Borcherding, D.C. and Ben-Jonathan, N. (2011) Prolactin in breast and prostate cancer: molecular and genetic perspectives. Discovery Med. 11, 315-324
40. Hu, Z.Z., Meng, J. and Dufau, M.L. (2001) Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J. Biol. Chem. 276, 41086-41094
41. Trott, J.F., Hovey, R.C., Koduri, S. and Vonderhaar, B.K. (2003) Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. J. Mol. Endocrinol. 30, 31-47 (Pubitemid 36305254)
42. Wang, H., Zhou, M., Shi, B., Zhang, Q., Jiang, H., Sun, Y., Liu, J., Zhou, K., Yao, M., Gu, J. et al. (2011) Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity. Neoplasia 13, 461-471
43. Wu, W., Ginsburg, E., Vonderhaar, B.K. and Walker, A.M. (2005) S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells. Cancer Res. 65, 7509-7515 (Pubitemid 41161287)
44. Huang, K.T. and Walker, A.M. (2010) Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity. Prostate 70, 37-47
45. Huang, P.H., Miraldi, E.R., Xu, A.M., Kundukulam, V.A., Del Rosario, A.M., Flynn, R.A., Cavenee, W.K., Furnari, F.B. and White, F.M. (2010) Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol. BioSyst. 6, 1227-1237
46. Yates, C.C., Shepard, C.R., Stolz, D.B. and Wells, A. (2007) Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br. J. Cancer 96, 1246-1252 (Pubitemid 46625074)
47. Sampson, J.H., Heimberger, A.B., Archer, G.E., Aldape, K.D., Friedman, A.H., Friedman, H.S., Gilbert, M.R., Herndon, II, J.E., McLendon, R.E., Mitchell, D.A. et al. (2010) Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J. Clin. Oncol. 28, 4722-4729
48. Wang, H., Shi, B., Zhang, Q., Jiang, H., Hu, S., Kong, J., Yao, M., Yang, S. and Li, Z. (2012) Growth and metastasis suppression of glioma xenografts expressing exon 4-deletion variant of epidermal growth factor receptor by monoclonal antibody CH12-mediated receptor degradation. FASEB J. 26, 73-80
49. Xu, Q. and Lee, C. (2003) Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res. 31, 5635-5643 (Pubitemid 37441935)
50. Das, S., Becker, B.N., Hoffmann, F.M. and Mertz, J.E. (2009) Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway. BMC Cell Biol. 10, 94